Luis Menendez, MD
Dermatology · Tampa, FLNPI 1871536615
Payments from drug & device makers
What this record shows
8 manufacturers reported payments, led by Pfizer at 58.9% of the total. Reporting peaked in 2020 at $2,488 and has fallen 95.8% since, to $104 in 2025.
Across 20 payments — averaging $200.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$2K
- AbbVie$1K
- Dermavant Sciences, Inc.$144
- Paratek Pharmaceuticals, Inc.$121
- Almirall LLC$107
- Galderma Laboratories, L.p.$104
- plus $42 from 2 others
Across 138 payments — averaging $6661.53 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$301K
- Sanofi US Services Inc.$279K
- Pfizer$100K
- Sun Pharmaceutical Industries Inc.$84K
- AbbVie$76K
- Galderma Laboratories, L.p.$46K
- plus $32K from 3 others
What the payments were for
- Travel & lodging$1,77544%
- Food & beverage$2,23656%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 4 | $2,363 |
| AbbVie | 10 | $1,130 |
| Dermavant Sciences, Inc. | 1 | $144 |
| Paratek Pharmaceuticals, Inc. | 1 | $121 |
| Almirall LLC | 1 | $107 |
| Galderma Laboratories, L.p. | 1 | $104 |
| Genentech USA, Inc. | 1 | $27 |
| Johnson & Johnson | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,011 in reported general payments places this provider in the 60th percentile of 1,147 dermatology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 102 | $4,717 |
| Ketoconazole | 175 | $2,147 |
| Metronidazole | 28 | $1,109 |
| Doxycycline Hyclate | 60 | $1,077 |
| Triamcinolone Acetonide | 122 | $599 |
| ValacyclovirValacyclovir Hcl | 17 | $437 |
| Mupirocin | 43 | $351 |
| Clindamycin Phosphate | 13 | $301 |
| Terbinafine Hcl | 13 | $270 |
| Hydroxyzine Hcl | 21 | $222 |
| Hydrocortisone | 39 | $214 |
| Minoxidil | 32 | $210 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Tampa
- Seth FormanTampa$407K
- Asha ShahTampa$332K
- Nishit PatelTampa$111K
- Francisco KerdelMiami$2.1M
- Brad GlickMargate$2M
- Robert KirsnerMiami$1.4M
- John MinniStuart$1.4M
- Gil YosipovitchMiami$1M
- Shino Bay AguileraFt Lauderdale$1M
- Robert SnyderPembroke Pines$1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.